Complement degradation products in rheumatoid arthritis synovial fluid. 1994

M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
November 1982, The Journal of the Association of Physicians of India,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
July 1974, Annals of internal medicine,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
December 1969, Annals of the New York Academy of Sciences,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
December 1983, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
January 1975, Rheumatology,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
April 1970, Nihon Seikeigeka Gakkai zasshi,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
June 1976, Annals of the rheumatic diseases,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
January 1981, Zeitschrift fur Rheumatologie,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
September 1980, British medical journal,
M Shingu, and Y Watanabe, and K Tomooka, and K Yoshioka, and E Ohtsuka, and M Nobunaga
March 2004, Autoimmunity reviews,
Copied contents to your clipboard!